Friday's Top 10 Articles, Videos on TheStreet
NEW YORK (TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.
The Next Big Thing in Biotech: Pfizer
Adam Feuerstein
Senior columnist Adam Feuerstein says Pfizer is the next big thing in biotech.
Biotech Stock Mailbag: Exelixis, Protalix, Arena
Adam Feuerstein
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
Will Apple's Stock Become Dead Money?
Rocco Pendola
Any objective look at investing in AAPL has to consider alternatives.
Gregg Greenberg
Mason's Maturity; Houston's Problem; Einhorn's Interrogation; Rupert Gets Rocked; Aubrey's Apology. Challenger: Not Enough Growth to Create Jobs
Debra Borchardt
John Challenger of Challenger Grey & Christmas believes the headwinds are too strong to see job growth like we saw at the beginning of the year. Business in Revenue Mode? You May Not Need Bank Loan
Laurie Kulikowski
The top 10 open-market insider purchases and sales filed at the SEC Wednesday. When Volkswagen Entered China
Ted Reed
In a new book, a German wise man recalls how VW shunted Chrysler aside in China. 401(k) Day Trading Turns a Happy 4
TheStreet Guest Contributor
Even with trouble lurking at nearly every turn, 401(k) day trading took my precious cargo to the next level. Dow Falls More Than 100 Points
Andrea Tse
The Dow tumbles after the government reports that only 115,000 jobs were added in the U.S. last month. Now Hiring ... Ninjas?
Elizabeth Blackwell
There are many ways for a company to position itself as innovative, but now even job titles are in play.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
